Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Priapism in Sickle Cell Anemia
source: Family Practice Notebook
year: 2018
summary/abstract:Priapism in Sickle Cell Anemia:
II. Epidemiology
Incidence of Priapism in Sickle Cell Anemia: 89% by age 20 years old
III. Management
Duration: Analgesics
IV Fluids
Do not transfuse for Priapism 4 hours
Administer above measures if not already attempted
Exchange transfusion (Risk of CVA symptoms)
Epidural Anesthesia
Related Content
-
Stigma and pain in adolescents hospitalized for sickle cell vasoocclusive pain episodesOBJECTIVES: Sickle cell disease (SCD) p...
-
Dental Health in Children with Sickle Cell DiseaseWhat is Sickle Cell Disease? Sickle Cel...
-
Patient Perspective: The Journey of Pain in Sickle Cell Diseasehttps://www.youtube.com/watch?v=F4raFO0e...
-
Phase 1 trial to test under-the-skin injection of sevuparin in sickle cell patientsModus Therapeutics is going to launch ...
-
SCD Patients Benefit From Early Rivipansel Treatment for VOCs, New Analyses ShowStarting treatment with rivipansel (GMI-...
-
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
-
Sickle Cell & PregnancySickle cell disease often becomes more s...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.